ThruFlo Endovascular Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.35M

  • Investors
  • 2

ThruFlo Endovascular General Information

Description

Operator of endovascular system intended to treat complex vascular aneurysms at bifurcation sites. The company is currently operating in Stealth Mode.

Contact Information

Website
thrufloendovascular.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 470 Wald
  • Irvine, CA 92618
  • United States
Primary Industry
Biotechnology
Corporate Office
  • 470 Wald
  • Irvine, CA 92618
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ThruFlo Endovascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 25-Mar-2026 $2.35M Completed Stealth
To view ThruFlo Endovascular’s complete valuation and funding history, request access »

ThruFlo Endovascular Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-2
Seed-1
To view ThruFlo Endovascular’s complete cap table history, request access »

ThruFlo Endovascular Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Meditech VC-Backed Company Minority
Device of Tomorrow Capital Venture Capital Minority
To view ThruFlo Endovascular’s complete investors history, request access »

Ready to get started?

Request a free trial

ThruFlo Endovascular FAQs

  • When was ThruFlo Endovascular founded?

    ThruFlo Endovascular was founded in 2022.

  • Where is ThruFlo Endovascular headquartered?

    ThruFlo Endovascular is headquartered in Irvine, CA.

  • What industry is ThruFlo Endovascular in?

    ThruFlo Endovascular’s primary industry is Biotechnology.

  • Is ThruFlo Endovascular a private or public company?

    ThruFlo Endovascular is a Private company.

  • What is the current valuation of ThruFlo Endovascular?

    The current valuation of ThruFlo Endovascular is .

  • What is ThruFlo Endovascular’s current revenue?

    The current revenue for ThruFlo Endovascular is .

  • How much funding has ThruFlo Endovascular raised over time?

    ThruFlo Endovascular has raised $2.35M.

  • Who are ThruFlo Endovascular’s investors?

    Atlas Meditech and Device of Tomorrow Capital have invested in ThruFlo Endovascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process